Empresa Vital Therapies Inc Nasdaq
Acciones
US92847R1041
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 01/01/17 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 01/12/19 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/01/17 |
Andreas Muehler
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/08/16 |
Jessica Breu
IRC | Investor Relations Contact | - | - |
Patrick Walsh
PRN | Corporate Officer/Principal | 41 | 14/10/21 |
Inderpal Singh
LAW | General Counsel | 58 | 01/06/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19/11/19 |
Tamar Howson
BRD | Director/Board Member | 75 | 11/10/19 |
Jörg Neermann
BRD | Director/Board Member | 57 | 01/04/19 |
Daniel Vitt
CEO | Chief Executive Officer | 55 | 01/01/17 |
Duane Nash
CHM | Chairman | 53 | 01/01/19 |
Richard Rudick
BRD | Director/Board Member | 73 | 26/04/23 |
Monika Tornsen
BRD | Director/Board Member | 45 | 05/07/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 90 079 016 | 83 120 924 ( 92,28 %) | 0 | 92,28 % |
Información de la empresa
Immunic, Inc.
1200 Avenue of the Americas Suite 200
10036, New York
+
http://www.immunic-therapeutics.com![Dirección Vital Therapies Inc](https://cdn.zonebourse.com/static/address/14966049.png)
Sector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,61 % | 121 mil M | |
+17,75 % | 110 mil M | |
+17,23 % | 25,98 mil M | |
-24,11 % | 19,27 mil M | |
-18,56 % | 15,99 mil M | |
-18,47 % | 15,66 mil M | |
-47,75 % | 14,5 mil M | |
+57,35 % | 14,47 mil M | |
+5,62 % | 13,91 mil M |